Jason Butler
Stock Analyst at Citizens JMP
(4.84)
# 438
Out of 5,119 analysts
714
Total ratings
49.1%
Success rate
17.2%
Average return
Main Sectors:
Stocks Rated by Jason Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HALO Halozyme Therapeutics | Reiterated: Buy | $93 → $149 | $103.63 | +43.78% | 50 | Nov 6, 2026 | |
| PGEN Precigen | Reiterated: Buy | $11 → $12 | $4.47 | +168.46% | 50 | Nov 5, 2026 | |
| RAPP Rapport Therapeutics | Reiterated: Buy | $80 → $91 | $24.44 | +272.34% | 7 | Oct 20, 2026 | |
| RZLT Rezolute | Reiterated: Buy | $11 → $15 | $3.88 | +286.60% | 34 | Oct 6, 2026 | |
| ACAD Acadia Pharmaceuticals | Reiterated: Buy | $36 → $33 | $21.23 | +55.44% | 50 | Sep 25, 2026 | |
| ARGX argenx SE | Reiterated: Buy | $932 → $1,200 | $927.21 | +29.42% | 44 | Aug 18, 2026 | |
| LONA LeonaBio | Reiterated: Buy | $18 → $17 | $4.42 | +285.05% | 36 | Aug 17, 2026 | |
| CYTK Cytokinetics | Reiterated: Buy | $96 → $110 | $53.69 | +104.88% | 63 | Aug 7, 2026 | |
| ZVRA Zevra Therapeutics | Reiterated: Buy | $25 → $28 | $11.59 | +141.59% | 11 | Aug 6, 2026 | |
| ABVX ABIVAX Société Anonyme | Reiterated: Buy | $131 → $187 | $85.73 | +118.13% | 14 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 → $39 | $18.61 | +109.56% | 24 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $62 → $55 | $6.93 | +693.65% | 3 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $20 | $7.97 | +150.94% | 27 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $14 | $2.42 | +478.51% | 19 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $18 | $2.82 | +538.30% | 2 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $10 | $4.39 | +127.79% | 19 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $6.72 | +182.74% | 1 | Nov 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $12 | $3.61 | n/a | 53 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $22 | $5.32 | n/a | 43 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 → $38 | $28.49 | n/a | 29 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0004 | n/a | 31 | Dec 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0111 | n/a | 38 | Dec 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.152 | n/a | 13 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.65 | n/a | 9 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 5 | Sep 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.85 | n/a | 5 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $58 → $70 | $88.74 | n/a | 3 | Jan 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.39 | n/a | 7 | Sep 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.30 | n/a | 3 | Mar 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 | $3.82 | n/a | 8 | Feb 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $1.92 | n/a | 1 | Oct 18, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $61 | $284.65 | n/a | 1 | Jul 28, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.90 | n/a | 5 | May 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $2 | $54.62 | n/a | 2 | Aug 16, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $8.42 | n/a | 1 | May 22, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $14.93 | n/a | 2 | May 6, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.74 | n/a | 1 | Mar 26, 2013 |
Halozyme Therapeutics
Nov 6, 2026
Reiterated: Buy
Price Target: $93 → $149
Current: $103.63
Upside: +43.78%
Precigen
Nov 5, 2026
Reiterated: Buy
Price Target: $11 → $12
Current: $4.47
Upside: +168.46%
Rapport Therapeutics
Oct 20, 2026
Reiterated: Buy
Price Target: $80 → $91
Current: $24.44
Upside: +272.34%
Rezolute
Oct 6, 2026
Reiterated: Buy
Price Target: $11 → $15
Current: $3.88
Upside: +286.60%
Acadia Pharmaceuticals
Sep 25, 2026
Reiterated: Buy
Price Target: $36 → $33
Current: $21.23
Upside: +55.44%
argenx SE
Aug 18, 2026
Reiterated: Buy
Price Target: $932 → $1,200
Current: $927.21
Upside: +29.42%
LeonaBio
Aug 17, 2026
Reiterated: Buy
Price Target: $18 → $17
Current: $4.42
Upside: +285.05%
Cytokinetics
Aug 7, 2026
Reiterated: Buy
Price Target: $96 → $110
Current: $53.69
Upside: +104.88%
Zevra Therapeutics
Aug 6, 2026
Reiterated: Buy
Price Target: $25 → $28
Current: $11.59
Upside: +141.59%
ABIVAX Société Anonyme
Jun 2, 2026
Reiterated: Buy
Price Target: $131 → $187
Current: $85.73
Upside: +118.13%
May 15, 2026
Reiterated: Buy
Price Target: $42 → $39
Current: $18.61
Upside: +109.56%
May 14, 2026
Reiterated: Buy
Price Target: $62 → $55
Current: $6.93
Upside: +693.65%
May 8, 2026
Reiterated: Buy
Price Target: $19 → $20
Current: $7.97
Upside: +150.94%
Apr 15, 2026
Initiated Coverage: Buy
Price Target: $14
Current: $2.42
Upside: +478.51%
Mar 26, 2026
Reiterated: Buy
Price Target: $19 → $18
Current: $2.82
Upside: +538.30%
Feb 26, 2026
Reiterated: Buy
Price Target: $8 → $10
Current: $4.39
Upside: +127.79%
Nov 25, 2025
Initiated Coverage: Buy
Price Target: $19
Current: $6.72
Upside: +182.74%
Oct 9, 2025
Reiterated: Buy
Price Target: $9 → $12
Current: $3.61
Upside: n/a
Sep 9, 2025
Reiterated: Buy
Price Target: $19 → $22
Current: $5.32
Upside: n/a
May 7, 2025
Reiterated: Buy
Price Target: $42 → $38
Current: $28.49
Upside: n/a
Dec 27, 2024
Rated: Hold
Price Target: n/a
Current: $0.0004
Upside: n/a
Dec 27, 2024
Downgraded: Hold
Price Target: n/a
Current: $0.0111
Upside: n/a
Nov 3, 2023
Rated: Hold
Price Target: n/a
Current: $0.152
Upside: n/a
Apr 6, 2023
Rated: Hold
Price Target: n/a
Current: $3.65
Upside: n/a
Sep 3, 2021
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Aug 16, 2021
Reiterated: Hold
Price Target: n/a
Current: $2.85
Upside: n/a
Jan 9, 2020
Reiterated: Buy
Price Target: $58 → $70
Current: $88.74
Upside: n/a
Sep 5, 2019
Downgraded: Hold
Price Target: n/a
Current: $2.39
Upside: n/a
Mar 28, 2019
Downgraded: Hold
Price Target: n/a
Current: $2.30
Upside: n/a
Feb 14, 2019
Reiterated: Buy
Price Target: $52
Current: $3.82
Upside: n/a
Oct 18, 2016
Reiterated: Buy
Price Target: $17
Current: $1.92
Upside: n/a
Jul 28, 2016
Reiterated: Buy
Price Target: $61
Current: $284.65
Upside: n/a
May 10, 2016
Reiterated: Hold
Price Target: n/a
Current: $3.90
Upside: n/a
Aug 16, 2013
Reiterated: Buy
Price Target: $6 → $2
Current: $54.62
Upside: n/a
May 22, 2013
Initiated Coverage: Hold
Price Target: n/a
Current: $8.42
Upside: n/a
May 6, 2013
Downgraded: Hold
Price Target: n/a
Current: $14.93
Upside: n/a
Mar 26, 2013
Downgraded: Hold
Price Target: n/a
Current: $1.74
Upside: n/a